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Background: The Fontan operation is standard palliation for single ventricle heart defects. Outcomes beyond 20 yrs after Fontan palliation are not 
well known. We describe late outcomes in a cohort of adult patients post-Fontan.
methods: A chart review of all patients post Fontan who survived to adulthood, seen at Emory since 1998 was performed. Diagnosis, surgical 
history, cardiac hospitalizations (heart failure, arrhythmia, thromboembolic events, or surgical admissions), death and need for transplant were 
obtained. Outcomes were plotted using Kaplan Meier and tested for difference by Fontan type and ventricular morphology.
results: 134 patients (57.5% male) were identified (mean age 28.4 yrs [18-55.2], mean time from Fontan completion 21.4 yrs [5.1-34.8]). 
Ventricular morphological was right (RV) n=31, left (LV) n=98, or equal ventricles n=5. 55 patients had atriopulmonary Fontan (APC), 24 of which 
were revised, 77 lateral tunnel, 2 extracardiac. 14 patients died, 10 required transplant. Fig. 1 shows overall survival. LV patients had improved 
survival compared to RV (p=0.035), with no differences by Fontan type. Freedom from hospitalization was 69%, 38.6%, and 6.4% at 20, 25 and 30 
yrs since Fontan, with no difference by Fontan type or ventricular morphology.
conclusions: In a cohort of Fontan patients with adult survival, hospitalization is common and transplant-free survival decreases with time since 
Fontan, approaching 50% at 30 yrs following Fontan. Systemic RV confers worse late survival.
 
